Tetrahydropalmatine

Tetrahydropalmatine (THP) is a naturally occurring isoquinoline alkaloid of the protoberberine class, found in plants of the genera Corydalis and Stephania that have been used in traditional Chinese medicine for centuries ^[3][5]. It is a principal active constituent of Corydalis yanhusuo (Rhizoma Corydalis), a herb prescribed historically for pain relief and calming effects ^[7]. The compound exists as two mirror-image forms, and the levorotatory enantiomer, levo-tetrahydropalmatine (L-THP, also known as rotundine), is the pharmacologically active form responsible for most of its effects ^[5].

Pharmacologically, THP is best characterized as an antagonist at dopamine receptors, with particular activity at the dopamine D2 receptor ^[1][2]. This dopamine-blocking action distinguishes it from opioid analgesics and underlies its traditional use as a sedative, sleep aid, and analgesic; in some Asian countries L-THP has been used clinically under the name rotundine for pain and anxiety ^[5][6].

Contemporary research has extended interest well beyond pain. A large body of preclinical work has examined L-THP as a candidate treatment for substance use disorders, reporting that it reduces the self-administration, reward, and relapse-related behavior associated with cocaine, nicotine, methamphetamine, and morphine in animal models ^[3][4][5]. It has also progressed into early human study: a randomized, double-blind, placebo-controlled trial found oral L-THP to be safe and well tolerated in cocaine users ^[1]. THP is available as a botanical extract and as an isolated alkaloid, is taken orally, and is not approved as a drug in the United States, where it is sold as a dietary supplement; work on improved formulations continues in order to enhance its oral bioavailability and brain penetration ^[7].

In traditional plant amounts it has a long, reassuring history. Because it blocks dopamine, the theoretical cautions are the same as mild antipsychotics: grogginess, and rarely, movement side effects with heavy chronic use. There have been rare reports of liver issues tied to Corydalis products, so quality and moderation matter, and it is sedating enough that you should not drive on it. Avoid stacking with other sedatives.

Tetrahydropalmatine (l-THP) is a substrate of and inhibitor at CYP3A and, to a lesser degree, CYP2D6; in vivo studies show CYP3A/2D6 inhibitors such as ketoconazole and quinidine markedly raise THP exposure (AUC increased roughly 4-fold in rats), and repeated THP dosing inhibits CYP3A-mediated midazolam metabolism in dogs, so co-administration with CYP3A substrates or inhibitors is a documented drug-interaction concern.

As a sedating dopamine D2 antagonist it can add to the CNS-depressant effects of alcohol, benzodiazepines, opioids and other sedatives, and its dopamine blockade is pharmacologically opposed to dopaminergic agents while potentially additive with antipsychotics for extrapyramidal risk. THP-containing preparations (e.g. Jin Bu Huan) have been linked to hepatotoxicity, which is relevant when combined with other hepatotoxic agents. Most human-scale interaction data are extrapolated from animal PK work and should be read as suggestive rather than fully established. This is research information, not medical advice.

Checking a whole stack? Run it through interactions + stacks.

L-Tetrahydropalmatine is a naturally occurring protoberberine alkaloid found in plants of the genera Corydalis and Stephania, which have been used in traditional Chinese medicine for centuries as remedies for pain and insomnia. The purified levo-enantiomer was characterized by Chinese pharmacologists in the mid-twentieth century, and it was subsequently approved and marketed in China as a sedative and analgesic under the drug name Rotundine.

From the 1990s onward, researchers began to define its receptor pharmacology, establishing that it antagonizes dopamine D1 and D2 receptors and interacts with D3, adrenergic, and serotonergic sites. This dopaminergic profile drew the attention of addiction scientists in the United States, notably groups at the University of Maryland and Baylor College of Medicine, who advanced it as a candidate treatment for cocaine and other stimulant use disorders. That translational effort, culminating in early human studies, gives L-THP an unusually developed evidence base for a plant alkaloid.

L-THP enjoys a strong reputation as one of the better studied botanical calming agents, bridging a long folk tradition with rigorous modern neuroscience. It is valued for a gentle sedative and anxiolytic quality that owes to dopamine modulation rather than the broad GABAergic depression of conventional sedatives, and its traditional use for sleep and discomfort is well documented.

The compound is perhaps most respected within addiction research, where preclinical work has repeatedly shown it can blunt the reinforcing effects of stimulants, and a human study found oral dosing to be safe and well tolerated. Its evidence base remains centered on animal models and early clinical work rather than large trials, so expectations should be measured. Even so, for those exploring naturally derived approaches to relaxation, L-THP stands out as a genuinely intriguing and comparatively well characterized molecule.